Valuation: InMode Ltd.

Market Cap 872M 766M 712M 654M 1.23B 83.97B 1.25B 8.46B 3.3B 41.28B 3.27B 3.2B 143B P/E 2026 *
13.1x
P/E 2027 * 11.9x
Enterprise Value 872M 766M 712M 654M 1.23B 83.97B 1.25B 8.46B 3.3B 41.28B 3.27B 3.2B 143B EV / Sales 2026 *
2.36x
EV / Sales 2027 * 2.3x
Free-Float
60.55%
Yield 2026 *
-
Yield 2027 * -
1 day+0.53%
1 week-1.94%
Current month+3.76%
1 month+2.57%
3 months+5.35%
6 months+8.75%
Current year+3.27%
1 week 14.99
Extreme 14.99
15.56
1 month 14.37
Extreme 14.37
15.67
Current year 12.72
Extreme 12.72
16.67
1 year 12.72
Extreme 12.72
16.74
3 years 12.72
Extreme 12.72
48.25
5 years 12.72
Extreme 12.72
99.27
10 years 6.53
Extreme 6.53
99.27
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2008
Chief Executive Officer 73 01/01/2008
Director of Finance/CFO 41 18/05/2026
Director TitleAgeSince
Chairman 73 01/01/2008
Director/Board Member 59 06/08/2019
Chairman 67 04/05/2026
Date Insider Type Main position Quantity % Market Cap.
19/05/26 Other

Chairman

0 0%
19/05/26 Other

Chief Financial Officer

26,733 0.0422%
18/03/26 Other

Chairman

10,000 0.0158%
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%-1.94%+4.40%-66.01% 872M
-0.71%+6.72%+19.63%-0.57% 211B
-0.52%-6.05%-5.58%-25.77% 135B
+1.65%-2.29%-30.93%+4.31% 119B
+1.54%+0.50%-58.34%-15.18% 65.77B
-1.42%-3.62%+9.01%-9.60% 47.58B
+3.03%-0.17%-26.81%-31.58% 44.44B
-0.84%+5.41%+15.14%+8.50% 39.14B
-2.02%+1.54%+25.53%+30.56% 36.79B
-1.41%+3.99%+80.31%+3.20% 29.37B
Average -0.02%+0.23%+3.24%-10.21% 72.9B
Weighted average by Cap. -0.00%+0.36%-1.37%-6.09%

Financials

2026 *2027 *
Net sales 370M 325M 302M 278M 521M 35.66B 529M 3.59B 1.4B 17.53B 1.39B 1.36B 60.61B 379M 333M 310M 284M 534M 36.5B 542M 3.68B 1.44B 17.94B 1.42B 1.39B 62.04B
Net income 72.86M 63.99M 59.51M 54.61M 103M 7.02B 104M 707M 276M 3.45B 274M 268M 11.93B 78.41M 68.86M 64.04M 58.77M 110M 7.55B 112M 760M 297M 3.71B 294M 288M 12.83B
Net Debt - -
Logo InMode Ltd.
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Employees
660
Date Price Change Volume
24/07/26 US$15.17 +0.53% 419,196
23/07/26 US$15.09 -0.72% 536,870
22/07/26 US$15.20 -1.04% 373,546
21/07/26 US$15.36 0.00% 387,930
20/07/26 US$15.36 -0.71% 444,804
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
15.17USD
Average target price
15.33USD
Spread / Average Target
+1.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INMD Stock